BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
Holding BMRN?
Track your performance easily

BioMarin Pharmaceutical (BMRN) Financial Statements

1,882 Followers

BioMarin Pharmaceutical Financial Overview

BioMarin Pharmaceutical's market cap is currently ―. The company's EPS TTM is $1.324; its P/E ratio is 53.71; BioMarin Pharmaceutical is scheduled to report earnings on October 23, 2024, and the estimated EPS forecast is $0.53. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 712.03M$ 648.83M$ 646.21M$ 581.33M$ 584.70M
Gross Profit$ 581.57M$ 523.65M$ 510.73M$ 456.58M$ 482.82M
EBIT$ 132.14M$ 109.09M$ 25.43M$ 45.45M$ 74.56M
EBITDA$ 162.09M$ 134.93M$ 50.83M$ 70.03M$ 98.45M
Net Income Common Stockholders$ 110.75M$ 88.66M$ 20.38M$ 71.74M$ 56.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.22B$ 1.05B$ 1.07B$ 1.13B$ 1.17B
Total Assets$ 7.07B$ 6.87B$ 6.84B$ 6.76B$ 6.56B
Total Debt$ 1.09B$ 1.09B$ 1.09B$ 1.09B$ 1.08B
Net Debt$ -135.40M$ 41.38M$ 13.16M$ -39.86M$ -85.96M
Total Liabilities$ 1.78B$ 1.80B$ 1.89B$ 1.86B$ 1.78B
Stockholders Equity$ 5.29B$ 5.07B$ 4.95B$ 4.90B$ 4.78B
Cash Flow-
Free Cash Flow$ 96.92M$ 12.87M$ -9.21M$ 112.23M$ 47.38M
Operating Cash Flow$ 118.76M$ 46.97M$ 27.48M$ 135.65M$ 70.11M
Investing Cash Flow$ 90.48M$ -14.24M$ -64.96M$ -45.80M$ 29.53M
Financing Cash Flow$ 12.61M$ -42.79M$ 10.84M$ -788.00K$ 11.96M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

BioMarin Pharmaceutical Debt to Assets

BioMarin Pharmaceutical Cash Flow

BioMarin Pharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis